USA flag logo/image

An Official Website of the United States Government

SBIR Phase II: Atlantic Cod Nodavirus Vaccine

Award Information

Agency:
National Science Foundation 		Branch:
N/A 		Award ID:
79603 		Program Year/Program:
2007 / SBIR
Agency Tracking Number:
0610512 		Solicitation Year:
N/A 		Solicitation Topic Code:
N/A 		Solicitation Number:
N/A
Small Business Information
Maine BioTek, Inc.
259 MAIN STREET Suite 208 WINTERPORT, ME 04496 0408
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2007
Title: SBIR Phase II: Atlantic Cod Nodavirus Vaccine
Agency: NSF
Contract: 0724041
Award Amount: $499,393.00
 

Abstract:

This Small Business Innovation Research (SBIR) Phase II project of develops a recombinant vaccine for the prevention of nodavirus disease of cultured Atlantic cod, fisheries of growing importanct to New England and Atlantic Canada. The recombinant technology used to build the vaccine is economical, safe and results in a potent and efficacious product that improves cod health. The research addresses recombinant antigen synthesis, formulation, safety, potency and efficacy. After translational development, manufacturing and regulatory approval, the vaccine will be available to cod producers for the prevention of nodavirus disease. The broader impacts of this research will be to enable more facile development of the nascent cod aquaculture industry in respect to methods of viral disease control through vaccination. This is in concert with the desire of the nation to increase aquacultural production significantly by 2020 without impacting the ocean environment negatively.

Principal Investigator:

Eric D. Anderson
PhD
2072234662
mainebiotek@hotmail.com

Business Contact:

Eric D. Anderson
PhD
2072234662
mainebiotek@hotmail.com
Small Business Information at Submission:

Maine BioTek, Inc.
259 MAIN STREET Suite 208 WINTERPORT, ME 04496

EIN/Tax ID:
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No